DOCS Dr. Martens plc
Dr. Martens plc engages in the design, development, procurement, marketing, sale, and distribution of footwear. The company sells its footwear under the Dr. Martens brand name in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. Dr. Martens plc was founded in 1945 and is based in London, the United Kingdom.…
Industry Peers
Footwear & AccessoriesKey Statistics
About Dr. Martens (LON: DOCS)
›
Dr. Martens (LON: DOCS) is listed on the London Stock Exchange, where its shares trade in pence sterling (GBp). It belongs to the Footwear & Accessories industry, part of the Consumer Cyclical sector, and reports about 3,600 employees.
The shares were at 54.50 GBp on 19 November 2026, down 36.8% over 52 weeks.
At a market capitalisation of 518.03M GBP, it trades at 18.2 times trailing earnings and 10.8 times forward earnings. The median trailing P/E of its 15 largest Footwear & Accessories peers is 12.7, a premium of 43% for DOCS. It pays a dividend yielding 4.55% (it pays out 91% of its earnings), against a median of 2.54% among the dividend payers in that peer group.
Dr. Martens reports return on equity of 6.6%, an operating margin of 9.1% and revenue down 9.8% year over year.
Its debt exceeds its cash by 309.80M GBP, a debt-to-equity ratio of 1.09. Its Piotroski F-score is 8 out of 9, a strong reading of its financial health. 6 analysts cover the stock, with an average rating of Buy; their mean price target of 83.00 GBp is 52.3% above the current price. The next earnings report is expected on 19 November 2026.